Adragos is a pharmaceutical contract manufacturer specializing in the development and production of medicinal products.
Erwerb sowie Halten und Verwalten von Beteiligungen an in- und ausländischen Gesellschaften.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 282245 (as of 4 November 2026)
| Name | Type | City |
|---|---|---|
| Andreas Raabe | Geschäftsführer(in) | München |
| Daniel Wigbers | Geschäftsführer(in) | Berlin |
| Company | Location |
|---|---|
| München |
Source: German Commercial Register (Handelsregister) München Local Court, HRB 282245 (as of 4 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €96,786,000 | -€2,490,000 | €277,658,000 | 764 |
| 2023 | €79,987,000 | €8,983,000 | €234,858,000 | 605 |
| 2022 | €42,737,000 | -€8,780,000 | €83,167,000 | 364 |
| 2021 | €10,992 | -€4,608 | €83,417 | 357 |
| 2020 | — | — | €88,164 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 282245 (as of 4 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €42,770,000 | 47.4% |
| Material Costs | €30,810,000 | 34.1% |
| Depreciation | €12,603,000 | 14.0% |
| Interest & Similar | €4,101,000 | 4.5% |
